Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT2i in PCOS
NCT05966792Completed
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Nov 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of henagliflozin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Menstrual cycles at 6 months. Started Nov 2023; status: completed.
02
Drugs
henagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05966792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05966792.